Immunocore Holdings (IMCR) Peer Comparison

$36.32

$-0.43 (-1.17%)

As on 28-Aug-2026 13:09EDT

Market cap

$1,899 Mln

Revenue (TTM)

$404 Mln

P/E Ratio

--

P/B Ratio

4.5

Div. Yield

0 %

Edit

	Immunocore Holdings (IMCR)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Market cap ($ Mln)	1,899	17,326	16,614	13,400	12,305
Revenue ($ Mln)	404	2,782	1,054	2,436	670
Net Profit ($ Mln)	-9.33	491.50	755.85	860.62	-319.95
Net Margin (%)	-2.31	17.67	71.69	35.33	-47.79
RoE (%)	-2.33	110.09	--	42.98	-71.14
Price to Earnings	--	36.49	19.38	17.01	--
Price-To-Book	4.46	39.43	10.05	7.27	26.44

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Immunocore Holdings (IMCR)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Operating Revenue	403.72	2,782.29	1,054.37	2,435.92	669.50
Cost of Revenue	4.66	1,982.07	103.47	85.67	19.14
Gross Profit	291.36	760.62	588.53	2,236.43	829.45
Operating Expenses	416.55	216.81	841.45	1,378.74	895.93
Operating Profit (EBIT)	-17.48	583.40	109.45	971.51	-226.44
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	1.36	598.92	101.11	1,035.47	-252.08
Provision for Tax	10.69	107.42	-654.74	174.84	20.05
Profit after Tax (Net Income)	-9.33	491.50	755.85	860.62	-319.95
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Immunocore Holdings (IMCR)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Shareholder's Funds	419.80	433.86	1,435.90	1,843.76	465.53
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Non-Current Liabilities	464.43	187.89	384.48	288.55	1,362.63
Current Liabilities	235.20	1,435.43	464.70	361.93	283.35
Total Liabilities	1,067.27	1,975.47	1,302.02	2,844.42	1,385.30

Assets ($ Mln)

	Immunocore Holdings (IMCR)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Non-Current Assets	68.38	1,006.90	895.24	1,243.41	440.60
Current Assets	1,051.04	1,050.29	1,389.84	1,250.82	1,671.41
Total Assets	1,067.27	1,975.47	1,302.02	2,844.42	1,385.30
Total Debt*	434.96	120.10	449.89	165.93	864.07
Net Current Assets	815.85	-385.14	0.00	888.90	1,388.07

Cashflow ($ Mln)

	Immunocore Holdings (IMCR)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Cash From Operating Activities	-7.97	713.22	51.77	884.27	179.55
Cash Flow from Investing Activities	-12.16	-31.14	-8.15	350.44	-129.29
Cash from Financing Activities	9.20	-860.39	34.89	-969.59	74.01
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Immunocore Holdings (IMCR)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
ROCE (%)	-3.28	53.56	-30.01	32.82	-0.17
ROE (%)	-2.33	110.09	163.18	42.98	-71.14
ROA (%)	-0.72	15.64	26.53	29.32	-16.12
EBIT Margin (%)	3.18	21.13	5.73	31.04	-0.77
Net Margin (%)	-2.31	17.67	71.69	35.33	-47.79
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Immunocore Holdings (IMCR)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Revenue Growth (%)	13.36	24.67	114.85	9.23	12.22
EBIT Growth (%)	376.52	18.70	136.39	-3.99	93.17
Net Profit Growth (%)	54.07	17.50	378.76	42.89	-115.58
EPS Growth (%)	52.72	26.84	353.27	50.42	-73.87
Book Value Growth (%)	6.62	164.02	816.12	-0.70	-13.57

Valuation Ratios

	Immunocore Holdings (IMCR)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Price / Earnings	-66.15	36.06	-59.76	15.79	-2,869.63
Price / Book Value	4.59	35.44	-80.42	5.72	10.04
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	3,409.38	28.08	-121.54	12.44	25.04
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Immunocore Holdings (IMCR)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debt to Equity	0.94	0.00	0.00	0.00	1.77
Short term debt to equity ratio	0.00	0.00	0.05	0.00	0.09
Current Ratio	4.47	0.73	2.99	3.46	5.90
Quick Ratio	4.44	0.73	2.32	3.38	5.90
Interest Coverage	1.12	--	1.62	--	-1.72

Operating Efficiency Ratios

	Immunocore Holdings (IMCR)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debtors to sales (%)	23.62	15.88	21.25	13.74	1.28
Asset Turnover	0.31	0.89	0.37	0.83	0.34
Receivable days	96.40	50.42	85.52	43.48	1.50
Inventory Days	358.21	--	1,056.70	96.17	--
Payable days	1,453.77	6.26	331.01	147.97	221.81
Cash Conversion Cycle	-999.16	--	811.21	-8.32	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly